Trial Profile
A study of ticagrelor in patients with acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2017 New trial record